Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?

by Costagliola C, Sbordone M, Gandolfi S, Cesari L, Furneri G, Fea AM
Published 2020

XEN® Gel Stent: A Comprehensive Review on Its Use as a Treatment Option for Refractory Glaucoma

by Fea AM, Durr GM, Marolo P, Malinverni L, Economou MA, Ahmed I
Published 2020

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone

by Zola M, Briamonte C, Lorenzi U, Machetta F, Grignolo FM, Fea AM
Published 2017

Recent developments in the management of dry age-related macular degeneration

by Buschini E, Fea AM, Lavia CA, Nassisi M, Pignata G, Zola M, Grignolo FM
Published 2015

Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes

by Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Giamporcaro JE, Hornbeak DM
Published 2018

Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication

by Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Wells JM, Giamporcaro JE
Published 2015

Prospective unmasked randomized evaluation of the iStent inject® versus two ocular hypotensive agents in patients with primary open-angle glaucoma

by Fea AM, Belda JI, Rękas M, Jünemann A, Chang L, Pablo L, Voskanyan L, Katz LJ
Published 2014